High Blood Pressure

High Blood Pressure Hypertension

Hypertension or high blood pressure is known as the "silent killer" because despite being one of the most common fatal conditions worldwide, most people are unaware they have the condition because it presents with very few or no symptoms.

What Causes High Blood Pressure?

Hypertension Symptoms and Effects

Hypertension Diagnosis

Hypertension Treatment

Anti-Hypertensive Drugs

High Blood Pressure in Children

Link between Bisphenol A and Increase in Blood Pressure

Hypertension Risk Factors

Ambulatory Blood Pressure Monitoring

Are Blood Pressure Monitors Accurate?

What is Obesity?

See more featured articles »

Causes of Obesity and Overweight

Obesity, What Can be Done?

What is Body Mass Index (BMI)?

Obesity and Fast Food

Obesity and Exercise

Obesity Management

Obesity and Blood Pressure

Obesity and Metabolic Syndrome

Obesity Epidemiology

What is Obesity Paradox?

Obesity and Periodontitis

Obesity in Children

Obesity and Respiratory Disorders

Obesity and Heart Disease

Obesity and Anesthesia

Obesity and Skin Problems

Fat Mass and Obesity-Associated Gene (FTO)

What does Sleeve Gastrectomy Involve?

Dieting for Obese Children

Abdominal Obesity and the Metabolic Syndrome

DASH Diet for High Blood Pressure

Solitary Kidney and High Blood Pressure Monitoring

Causes of angina

Risk Factors for Atherosclerosis

High Cholesterol and Stroke Risk

Latest High Blood Pressure News and Research

New nasal spray form of bumetanide shows promise for heart failure treatment

A new nasal spray form of the medication bumetanide may reduce the tissue swelling caused by heart failure as effectively as the standard oral and intravenous formulations of the medication, according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2024.

19 Nov 2024

Blood pressure control improved with dual medication pills in India

Medication variations that combined two of three different blood pressure-lowering medications into a single pill worked equally well in reducing blood pressure and were safe among adults in India, according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2024.

18 Nov 2024

Hypertension drug may reduce heart failure risk in people recovering from heart attack

New research found that the medication spironolactone, often prescribed for hypertension (high blood pressure), may reduce the risk of heart failure in people recovering from a heart attack.

18 Nov 2024

Intensive blood pressure treatment reduces cardiovascular risk in people with Type 2 diabetes

An intensive treatment approach to lowering high systolic blood pressure in people with Type 2 diabetes led to a reduced risk of heart attack, stroke, heart failure and death due to cardiovascular disease when compared to a standard treatment approach, according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2024.

18 Nov 2024

Anticoagulants fail to reduce cognitive decline in younger adults with AFib

Prescribing anti-clotting medications to adults younger than age 65 who have atrial fibrillation (AFib) but no other risk factors for stroke did not reduce the risk of cognitive decline, stroke or transient ischemic attack (TIA), according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2024.

18 Nov 2024

Vitamin D may lower blood pressure in older people with obesity

Vitamin D3 supplementation with calcium reduces blood pressure in elderly, overweight individuals, particularly those with higher BMI and existing hypertension.

14 Nov 2024

Primary care clinicians key to achieving optimal cardiovascular health

Primary care clinicians and practices are uniquely positioned to help people achieve optimal cardiovascular health through screening, diagnosing and treating the health behaviors and factors outlined in the American Heart Association's Life's Essential 8 health metrics to reduce the risk for heart disease and stroke, according to a new scientific statement published today in the Association's peer-reviewed journal Circulation: Cardiovascular Quality and Outcomes.

13 Nov 2024

New initiative aims to tackle high blood pressure in Philadelphia communities

At least 33% of people in Philadelphia – more in West and Southwest Philadelphia – suffer from high blood pressure. But many of them don't know it – that's why the condition, also known as hypertension, is known as "the silent killer."

13 Nov 2024

High blood pressure, atrial fibrillation and smoking linked to severe stroke risk

People with conditions or habits such as high blood pressure, an irregular heartbeat called atrial fibrillation, or smoking, not only have a higher risk of stroke, they may also have more severe strokes than people without these risk factors, according to a study published in the November 13, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

13 Nov 2024

Comparing camel, cow, and goat milk: Which is best for diabetes and heart health?

Camel milk's nutritional profile supports diabetes and heart health, offering superior metabolic benefits over cow and goat milk for chronic disease management.

13 Nov 2024

Extra hour of weekly exercise reduces risk of atrial fibrillation

Adding an extra hour every week of physical activity may lower the chance of developing the most common type of irregular heartbeat (arrythmia) by 11 percent, a new study shows.

12 Nov 2024

Getting enough sleep linked to lower hypertension risk in teens

Adolescents who meet the recommended guidelines of nine to 11 hours of sleep per day were shown to have a significantly lower risk of hypertension, according to a new study from UTHealth Houston.

11 Nov 2024

Historical redlining continues to affect HIV treatment in affected communities

A new study from Tulane University finds that historical race-based lending practices are still impacting health today, linking these discriminatory policies to delays in effective HIV treatment within affected neighborhoods.

11 Nov 2024

Obesity-related heart disease deaths rise sharply in the U.S. between 1999 and 2020

Heart disease deaths related to obesity increased by 180% in the U.S. between 1999 and 2020, especially among middle-aged men, Black adults, residents of Midwestern states and non-metropolitan areas, according to a preliminary study to be presented at the American Heart Association's Scientific Sessions 2024.

11 Nov 2024

AI-based video system may offer quick, no-contact screenings for high blood pressure and diabetes

A new system that combines high-speed video and an artificial intelligence (AI)-powered algorithm may offer quick, no-contact screenings for high blood pressure and Type 1 or Type 2 diabetes without needing blood tests, blood pressure cuffs or expensive wearable devices, according to a preliminary study to be presented at the American Heart Association's Scientific Sessions 2024.

11 Nov 2024

MESA heart disease risk score performs well even without race modifiers

A version of the MESA heart disease risk score that did not include race predicted heart disease risk just as well as the version that includes race, according to a preliminary study presented today at the American Heart Association's Scientific Sessions 2024.

11 Nov 2024

Redlining and its lasting impact on heart disease and diabetes

Heart disease, Type 2 diabetes, high blood pressure and obesity were more common and linked to reduced access to healthy foods among people who live in neighborhoods previously subjected to redlining, according to a preliminary study to be presented at the American Heart Association's Scientific Sessions 2024.

11 Nov 2024

Adipo Therapeutics shares results of studies on potential obesity treatment

Adipo Therapeutics LLC, a late-stage, preclinical biopharmaceutical company developing a potential treatment for obesity and related metabolic disorders, presented data from two studies at the annual meeting of The Obesity Society in San Antonio.

7 Nov 2024

Metabolic surgery cuts diuretic dependence in heart failure patients

Pennington Biomedical Research Center researchers at the Metamor Institute, along with colleagues from Our Lady of the Lake and LSU Health-New Orleans, have recently determined that metabolic surgery on patients with heart failure can result in a reduction in the need for oral diuretics, which are used to manage symptoms such as venous and vascular pressures.

7 Nov 2024

Hourglass-shaped stent shows promise for treating microvascular disease

A study at Mayo Clinic suggests that an hourglass-shaped stent could improve blood flow and ease severe and reoccurring chest pain in people with microvascular disease.

7 Nov 2024